Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/5979
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-03-24T14:21:55Z-
dc.date.available2022-03-24T14:21:55Z-
dc.date.issued2020-03-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/5979-
dc.language.isootherpt_BR
dc.publisherINCApt_BR
dc.subjectSegurança do Pacientept_BR
dc.subjectPatient Safetypt_BR
dc.subjectSeguridad del Pacientept_BR
dc.subjectInstituto Nacional do Câncer IIpt_BR
dc.titleHC II é atestado pela Anvisa por práticas de segurança do pacientept_BR
dc.title.alternativeInforme INCA 393pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 393

Files in This Item:
File Description SizeFormat 
Informe-INCA-2020-393-6-HC II-e-atestado.pdf288.82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.